Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 5Recruiting 4Unknown 2Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

NET 3Endocrine 3Gastrointestinal 2

Conditions

Neuroendocrine Tumors 3Rectal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Neuroendocrine 1Anastomotic Leak 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Somatostatin × Clear all
NCT07605611 2026-05-26

SC-Stoma

Tongji Hospital

Phase NA Recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Recruiting
60 enrolled
EndocrineNET

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06855095 2025-03-03

ATSA

The Netherlands Cancer Institute

Phase 2/3 Recruiting
39 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05701241 2024-06-14

SAUNA

University Hospital, Antwerp

Phase 4 Recruiting
270 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡